Results 11 to 20 of about 33,131 (314)

The efficacy of luteal phase support in women with polycystic ovary syndrome following assisted reproductive technology: a systematic review [PDF]

open access: diamondMiddle East Fertility Society Journal
Background Polycystic ovary syndrome (PCOS) is a complex endocrine condition prevalent among a significant number of women during their reproductive years.
Achmad Kemal Harzif   +7 more
doaj   +2 more sources

Endometrin as luteal phase support in assisted reproduction [PDF]

open access: bronzeFertility and Sterility, 2012
To compare clinical pregnancy rate (PR) and live birth rate (LBR) between Endometrin monotherapy versus Endometrin and P in oil combination therapy in assisted reproductive technology (ART) cycles.Retrospective analysis.Large private practice.Patients undergoing autologous fresh IVF cycles, autologous frozen ET cycles, and fresh oocyte donor cycles ...
Eve C. Feinberg   +4 more
openalex   +3 more sources

GnRH agonist as a luteal support in IVF cycle: mini-review—is there a role?

open access: yesMiddle East Fertility Society Journal, 2022
Background It has been established that assisted reproductive technology (ART) cycles are usually accompanied by a defective luteal phase, and that luteal phase support (LPS) is mandatory to improve reproductive outcomes.
Hasan Maghraby   +3 more
doaj   +1 more source

The inadequate corpus luteum

open access: yesReproduction and Fertility, 2021
The corpus luteum is the source of progesterone in the luteal phase of the cycle and the initial two-thirds of the first trimester of pregnancy. Normal luteal function is required for fertility and the maintenance of pregnancy.
W Colin Duncan
doaj   +1 more source

Comparison of two micronized progesterones (Lutogel and Eutrogenic) in support of the luteal phase in patients undergoing IVF [PDF]

open access: yesMajallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2021
Introduction: Luteal phase support is an inevitable part of IVF programs, for this purpose, progestogenic therapies are used. Lutogel and Utrogestan are two progestogenic therapies that can be used as supportive drugs for the luteal phase.
Sedigheh Hosseini   +4 more
doaj   +1 more source

Luteal Support and Risk of Ovarian Hyperstimulation in Assisted Reproduction (A Review)

open access: yesКубанский научный медицинский вестник, 2020
Background. Gonadotropin-releasing hormone agonist as an ovulation trigger effectively reduces the ovarian hyperstimulation risk in in vitro fertilisation protocols, at the same time requiring an effective luteal phase support in embryo transfer cycles ...
V. A. Krutova, A. A. Baklakova
doaj   +1 more source

Home - About - Disclaimer - Privacy